DarioHealth Corp Tangible Asset Value Trend

DRIO -- USA Stock  

USD 1.31  0.04  2.96%

This module enables investors to look at DarioHealth Corp various fundamental indicators over time in order to gain insight into the company future performance. Macroaxis historical fundamental analysis tools allow evaluation of not only typical financial statement drivers such as Cost of Revenue of 2 M, Gross Profit of 1.3 M or Interest Expense of 2 M, but also many exotic indicators such as Asset Turnover of 0.2659, Current Ratio of 3.7 or Free Cash Flow per Share of 0.43. This module is a perfect complement to use when analyzing DarioHealth Corp Valuation or Volatility. It can also complement various DarioHealth Corp Technical models. Additionally see analysis of DarioHealth Corp Correlation with competitors.
Showing smoothed Tangible Asset Value of DarioHealth Corp with missing and latest data points interpolated. The value of tangibles assets calculated as the difference between Total Assets and intangible assets.
Tangible Asset Value10 Years Trend
Slightly volatile
 Tangible Asset Value 

Regression Statistics

Arithmetic Mean  3,524,472
Geometric Mean  3,275,916
Coefficient Of Variation  40.62
Mean Deviation  1,282,931
Median  3,081,000
Standard Deviation  1,431,559
Range  3,657,488
R Value  0.90
R Squared  0.81
Significance  0.00006304
Slope  357,769

DarioHealth Corp Tangible Asset Value Over Time

2016-12-31  5,077,000 
2017-12-31  5,077,000 
2018-12-31  5,972,941 

Other Fundumenentals

Thematic Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Thematic Ideas
Explore Investing Ideas  
Additionally see analysis of DarioHealth Corp Correlation with competitors. Please also try Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.